SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001387131-23-012195
Filing Date
2023-10-12
Accepted
2023-10-12 16:22:34
Documents
14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT dmk_defc14a-101123.htm DEFC14A 898939
2 GRAPHIC dmk_proxycard001.jpg GRAPHIC 7333
3 GRAPHIC image_001.jpg GRAPHIC 5469
4 GRAPHIC image_003.jpg GRAPHIC 83360
5 GRAPHIC image_004.jpg GRAPHIC 88578
6 GRAPHIC img_001.jpg GRAPHIC 6294
7 GRAPHIC img_002.gif GRAPHIC 1659
8 GRAPHIC img_002.jpg GRAPHIC 6297
9 GRAPHIC img_003.gif GRAPHIC 1657
10 GRAPHIC img_003.jpg GRAPHIC 4335
11 GRAPHIC img_004.gif GRAPHIC 7412
12 GRAPHIC img_004.jpg GRAPHIC 3879
13 GRAPHIC img_005.jpg GRAPHIC 4418
14 GRAPHIC img_006.jpg GRAPHIC 3937
  Complete submission text file 0001387131-23-012195.txt   1211961
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filed by) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-36242 | Film No.: 231322953
SIC: 2834 Pharmaceutical Preparations